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．PROGNOSTIC OBSERVATION OF TESTICULAR TUMOR
             FOR THE LAST SEVEN YEARS
Akira DEMuRA， Noboru TAKAsAKi and Shigeru MiyAzAKi
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              （Director： Prof． S． Mi azaki， M． D．）
   The results of treatment and the survival of 31 patients with testi’cular tumors admitted to the
department of Vrology， Osaka Medical School for 7 years from 1972 to 1978 were investigated．
   1． As our principle， orchiectomy and retroperitoneal lymph node dissection were performed
at the first・step in thc treatment leaving histological types out of consideration and ．thereafter chemo－
thgrapy apd irradiation were done．・
   2． The overall observed three and five year survival ．rates were 78．6 and 73．2 per cent respectively．
   3． The survival study on patients with different’histological types of testicular tumor revealed
that the observed three and five year survival rates wei：e 79 per cent in seminomas， and 77 and 67 per
cent respectively in non－seminomateus tumors．
   4．The correlation betwen the duratio血肋In the de＞elopment of symptoms to the丘rst medical
examination and the prognosis was net foUnd．
   5． High correlation between the clinical stage and the prognosis was recognized since the observed
five survivai rate in stage IA was i OO per cent and as more the stage advanced， the survival’ rate was
lower．
   However， it was proved that even if the retroperitoneal lymph node rpetastasis were evidenced
（stage IB or II）， higher survival rate，was expected by retroperitoneal lyrnph node dissection．
            ．緒   ． 言
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Fig．5．治療法別の実測生存率

















びV群の症例は病期的にみると，stage I 1例， stage














            非精上皮腫郭清（一）
12345術後年数Fig．6．組織型別および郭清術の



























はstage Iの5年実測生存率97％， stage IIでは77
％，stage III 20％と報告し， Maierら7）は精上皮腫
については，5年生存率はStage IAでは97％， stage
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